Plexiform fibrohistiocytic tumor
| Plexiform fibrohistiocytic tumor | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Oncology, Pathology |
| Symptoms | Painless mass |
| Complications | N/A |
| Onset | Typically in children and young adults |
| Duration | |
| Types | |
| Causes | Unknown |
| Risks | |
| Diagnosis | Histopathology |
| Differential diagnosis | Fibrous histiocytoma, Dermatofibrosarcoma protuberans, Neurofibroma |
| Prevention | |
| Treatment | Surgical excision |
| Medication | |
| Prognosis | Generally benign, but can recur |
| Frequency | Rare |
| Deaths | N/A |
Plexiform fibrohistiocytic tumor (PFHT) is a rare type of soft tissue tumor that typically occurs in children and young adults. It was first described in the medical literature in 1988. PFHT is considered a low-grade malignancy, meaning it has the potential to spread to other parts of the body, but this is uncommon.
Signs and Symptoms[edit]
Patients with PFHT typically present with a slow-growing, painless mass. The most common locations for these tumors are the upper extremities, followed by the head and neck region. However, they can occur anywhere in the body.
Diagnosis[edit]
The diagnosis of PFHT is made based on the findings of a biopsy of the tumor. The tumor is composed of a mixture of fibroblasts and histiocytes, arranged in a distinctive plexiform pattern. The cells are typically spindle-shaped and have a moderate amount of cytoplasm. There may also be areas of necrosis or hemorrhage within the tumor.
Treatment[edit]
The primary treatment for PFHT is surgical removal of the tumor. In some cases, chemotherapy or radiation therapy may be used as well.
Prognosis[edit]
The prognosis for patients with PFHT is generally good, with a high rate of long-term survival. However, the tumor can recur in up to one-third of cases, and metastasis can occur, although this is rare.